First National Bank of Omaha decreased its holdings in shares of CME Group Inc (NASDAQ:CME) by 1.5% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 45,029 shares of the financial services provider’s stock after selling 687 shares during the period. First National Bank of Omaha’s holdings in CME Group were worth $7,664,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also added to or reduced their stakes in the business. Meeder Asset Management Inc. raised its position in shares of CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after acquiring an additional 362 shares in the last quarter. Kaizen Advisory LLC raised its position in shares of CME Group by 151.9% in the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after acquiring an additional 492 shares in the last quarter. Bbva Compass Bancshares Inc. bought a new position in shares of CME Group in the 3rd quarter worth approximately $134,000. Sun Life Financial INC raised its position in shares of CME Group by 267.7% in the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock worth $151,000 after acquiring an additional 672 shares in the last quarter. Finally, Cornerstone Wealth Management LLC bought a new position in shares of CME Group in the 2nd quarter worth approximately $153,000. 84.28% of the stock is owned by institutional investors and hedge funds.
CME Group stock opened at $186.40 on Wednesday. The company has a current ratio of 1.09, a quick ratio of 1.08 and a debt-to-equity ratio of 0.15. The company has a market capitalization of $62.42 billion, a P/E ratio of 39.08, a P/E/G ratio of 3.47 and a beta of 0.49. CME Group Inc has a twelve month low of $136.35 and a twelve month high of $188.49.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, October 25th. The financial services provider reported $1.45 earnings per share for the quarter, topping the consensus estimate of $1.42 by $0.03. The company had revenue of $904.20 million for the quarter, compared to the consensus estimate of $910.50 million. CME Group had a return on equity of 9.18% and a net margin of 113.67%. On average, analysts expect that CME Group Inc will post 6.63 EPS for the current fiscal year.
In related news, Director Ronald A. Pankau sold 260 shares of the company’s stock in a transaction that occurred on Thursday, August 9th. The stock was sold at an average price of $163.17, for a total value of $42,424.20. Following the sale, the director now owns 3,900 shares in the company, valued at approximately $636,363. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Martin J. Gepsman sold 300 shares of the company’s stock in a transaction that occurred on Thursday, September 13th. The stock was sold at an average price of $172.30, for a total value of $51,690.00. Following the completion of the sale, the director now owns 42,912 shares in the company, valued at approximately $7,393,737.60. The disclosure for this sale can be found here. Insiders sold a total of 20,479 shares of company stock worth $3,622,694 in the last 90 days. 0.43% of the stock is currently owned by company insiders.
CME has been the subject of several research reports. BidaskClub lowered CME Group from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Zacks Investment Research lowered CME Group from a “hold” rating to a “sell” rating in a research report on Wednesday, August 22nd. Jefferies Financial Group reissued a “buy” rating and issued a $190.00 target price on shares of CME Group in a research report on Wednesday, September 5th. Rosenblatt Securities initiated coverage on CME Group in a research report on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 target price for the company. Finally, Berenberg Bank set a $184.00 target price on CME Group and gave the stock a “hold” rating in a research report on Thursday, September 20th. Five equities research analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the stock. The company presently has an average rating of “Buy” and an average target price of $182.69.
TRADEMARK VIOLATION WARNING: This story was reported by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this story can be accessed at https://www.dispatchtribunal.com/2018/11/07/cme-group-inc-cme-holdings-reduced-by-first-national-bank-of-omaha.html.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.
See Also: Why is the ex-dividend date different from the record date?
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.